Precision Medicine Global Marketing Lead
Astellas Pharma
Summary
This position will report directly into the Head, SBM (Strategic Brand Marketing) Precision Medicine, and will work in close partnership with cross-functional partners including Medical & Development (M&D), Companion Diagnostic (CDx) Partners, Global Brand Marketing, Affiliate Marketing, Regulatory, Legal, Market Access and other functions to facilitate successful diagnostic launches.
Job description
Purpose and Scope
This position will report directly into the Head, SBM (Strategic Brand Marketing) Precision Medicine, and will work in close partnership with cross-functional partners including Medical & Development (M&D), Companion Diagnostic (CDx) Partners, Global Brand Marketing, Affiliate Marketing, Regulatory, Legal, Market Access and other functions to facilitate successful diagnostic launches.
Responsibilities and Accountabilities
- Strategy Lead for Select Biomarkers / Indications – Develop and lead Precision Medicine Strategy for select biomarker programs (e.g. CLDN18.2 for Pancreatic Cancer & KRAS) including Commercial CDx partner evaluation, PM strategic plan / iGBP, launch planning, core global materials, KEEs, DTE and coordination with other PM colleagues to ensure implementation and localization in key geographies US Support: late-stage Biomarkers / Indications – oversee pull through of Precision Medicine launch/commercialization strategy including DTE, market research, ad boards, material development and MLR review
- Global PM Above Brand Lead - CDx Partner commercial governance, cross-functional stakeholder management, Precision Medicine Enterprise strategy/metric development, diagnostic testing education (DTE) development process, Pathologist KEE strategy and Global channel strategy for affiliate adoption of Global diagnostic strategy
- Lead commercial assessment, recommendations for specific diagnostic opportunities and pull through of commercialization agreement deliverables/timing
- Lead commercial evaluation of companion diagnostics platforms, actively seek new products/technologies, effectively partner and foster key collaboration with appropriate industry, academics, and government partners
- Provide diagnostic leadership, support and expertise to Global and US Precision Medicine counterparts and cross-functional partners
- Develop Precision Medicine strategy and corresponding marketing/operationalization plans to drive implementation for affiliates
- Lead Dx insight generation priorities working closely with Commercial Insights
- Garner and incorporate Commercial Insights into Global Diagnostic strategy
- Define precision medicine KPIs, scorecards and analyze performance of programs and select biomarkers / indications on an ongoing basis
- Support and lead agency relationships, workflow, and related expense budgets to establish the DTE communication pillars, scientific narrative and messaging for select biomarkers / indications
- Develop and manage Global Key External Expert (KEE) steering committee to gain insight and alignment on diagnostic strategy recommendations
- Development, evolution and management of all aspects of the virtual pathology account manager program (vPAM) across tumor/test types to align with Global strategy, including pull through with SBM Precision Medicine leads
- Support US pull through of Global Precision Medicine strategy including DTE localization and market research, ad boards, material development and MLR review
- Lead implementation and evolution of Enterprise Precision Medicine Ecosystem
- Ensure adherence to Astellas policies relating to Ethics and Compliance standards and interactions with Healthcare Professionals (HCPs), Healthcare Organizations (HCOs) and Patient Organizations (POs).
Qualifications
Required Qualifications:
- Bachelor's Degree in Biology, Molecular Biology or other scientific discipline
- Prior Diagnostic (CDx) / Medical Device & Pharma marketing experience within Oncology
- Regional Diagnostic launch experience
- Technical understanding of diagnostic technologies
- 7+ years experience in pharmaceutical and/or healthcare industry
- Strategic thinking skills to create a robust business case, analyze commercial and business information and devise strategy.
- Willingness to travel 10-15% of the time
Preferred Qualifications:
- Advanced degree (Ph.D in Life Science, MBA, Medical, or Pharmacy)
Location and Working Environment
This position is based in Northbrook, IL. Remote work from anywhere in the US is available. At Astellas we recognize the importance of work/life balance, and we are proud to offer a hybrid working solution allowing time to connect with colleagues at the office with the flexibility to also work from home. We believe this will optimize the most productive work environment for all employees to succeed and deliver. Hybrid work from certain locations may be permitted in accordance with Astellas’ Responsible Flexibility Guidelines. This position is a global role with strong interaction with various disciplines and international stakeholders. Highly matrixed environment requiring cross-regional coordination. Frequent interaction with senior leadership and governance bodies. Collaboration across EU, US, and Japan time zones.
Requirements
- Bachelor's Degree in Biology, Molecular Biology or other scientific discipline
- Prior Diagnostic (CDx) / Medical Device & Pharma marketing experience within Oncology
- Regional Diagnostic launch experience
- Technical understanding of diagnostic technologies
- 7+ years experience in pharmaceutical and/or healthcare industry
- Strategic thinking skills to create a robust business case, analyze commercial and business information and devise strategy.
- Willingness to travel 10-15% of the time
- Advanced degree (Ph.D in Life Science, MBA, Medical, or Pharmacy) preferred
Benefits
- Medical, Dental & Vision
- Paid Time Off
- 401(k) Matching
- Life Insurance
- Annual Corporate Bonus
- Quarterly Sales Incentive
- Long Term Incentive Plan
- Company Fleet Vehicle
- Referral Bonus Program
Company overview
Astellas Pharma Inc. is a leading Japanese multinational pharmaceutical company headquartered in Tokyo, Japan. Founded in April 2005 through the merger of Yamanouchi Pharmaceutical (established 1923) and Fujisawa Pharmaceutical (established 1894), Astellas has grown into a global life sciences company with operations in more than 70 countries worldwide. The company employs approximately 14,500 people globally and generates annual revenues exceeding $12 billion. Astellas is committed to turning innovative science into value for patients through transformative therapies in key therapeutic areas including oncology, ophthalmology, urology, immunology, and women's health. The company's notable products include Xtandi for prostate cancer, Padcev for bladder cancer, Xospata for acute myeloid leukemia, Veozah for menopausal symptoms, and Izervay for geographic atrophy. With a strong focus on research and development, Astellas invests approximately 17% of its sales revenue into pioneering new healthcare solutions for diseases with high unmet medical needs. The company operates multiple research centers in Japan, the United States, and Europe, and has established strategic partnerships and acquisitions to expand its pipeline and capabilities in areas such as gene therapy and immuno-oncology.